Tag Archives: Emerging Pharma Leaders

Emerging Pharma Leaders: Michael Injaychock, Eli Lilly & Co.

Michael Injaychock joined Eli Lilly in 2007 after five years in a Washington-based financial services consulting role and a subsequent MBA from the University of North Carolina. Course work there as well as a stiff self-evaluation of his former job led Injaychock to conclude his future lay in a post that carried a larger purpose. “I […]
Posted in leadership, People | Also tagged , | Leave a comment

Emerging Pharma Leaders: Jamey Millar, GSK

Storytelling, since time immemorial, has served an important role in conveying information, expectations, and obligations. Stories can function as orientation guides, uniting readers or listeners around a common set of assumptions. The best stories also contain an element of surprise, a reminder of the unexpected possibilities, and chance occurrences that bind our lives together. After […]
Posted in leadership | Also tagged , | Leave a comment

Emerging Pharma Leaders: Ian Harris, Janssen Research & Development

When he left school, Ian Harris wanted a career in brewing. He enrolled on a biochemistry degree with the intention of going on to study a master’s in brewing at Heriot-Watt University in Edinburgh, UK. But after spending, as part of his first degree, a year in the pharmacutical industry developing in vitro disease models for dermatology […]
Posted in leadership, People | Tagged | Leave a comment

Emerging Pharma Leaders: Susanne Heinzinger

Susanne Heinzinger, Executive Director of Product Strategy and Alliance Management, Achillion Pharmaceuticals. To say that Susanne Heinzinger’s career trajectory has taken her from one spectrum of the healthcare arena to another may be an understatement. Before entering the pharmaceutical industry as a sales person, Heinzinger, who earned a Bachelor of Business Administration degree in accounting, […]
Posted in leadership | Also tagged | Leave a comment

Emerging Pharma Leader: Joerg Ahlgrimm, Baxter BioScience

By the middle of 2015, global healthcare giant Baxter International Inc. is expected to officially split off its BioScience business, establishing the unit as an independent, innovation-focused biotechnology company. Helming the operational component of these pursuits will be Joerg Ahlgrimm, 41, the division’s current vice president of operations and global supply chain. Ahlgrimm was appointed […]
Posted in leadership, Strategy | Also tagged , | Leave a comment
  • Categories

  • Meta